Year-over-year earnings per share growth for the last twelve months: IO Biotech, Inc. (IOBT)

iobiotech.com (IOBT) - corporate logo

IO Biotech, Inc. (IOBT) is implementing ESG standards by reducing chemical waste during drug development. On GURU.Markets, historical quarterly EPS growth demonstrates profit dynamics, where 0.00 captures the magnitude of this parameter. The brand is highly valued in the US and Denmark for its innovations in combating metastases. Flawless cold-chain logistics ensure the timely delivery of vaccines for testing.

IO Biotech Inc (IOBT) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 04/18/2026

Comprehensive metric breakdowns and analytics for IO Biotech Inc. (IOBT)

- share price and expert price forecast:
Stock Price IO Biotech|IOBT - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value IO Biotech Corp|IOBT - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share IO Biotech|IOBT - Company Net Assets|Market Cap to Net Assets Ratio iobiotech.com|IOBT - Company Total Assets
- debt and liquidity details:
Debt to Equity IO Biotech, Inc.|IOBT - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity IO Biotech, Inc.|IOBT - Company Cumulative Debt|Debt to Book Value IO Biotech Corp|IOBT - Long-Term Indebtedness|Company Current Liabilities IO Biotech|Quick Ratio iobiotech.com
- earnings and market multiples details:
IOBT - Final Profit|Projected Future Earnings IO Biotech, Inc.|IOBT - Market Cap to Earnings|Future Price to Earnings IO Biotech Corp|IOBT - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple IO Biotech Corp|IOBT - Operating profit EBITDA|Earnings per share for the last twelve months IO Biotech|IOBT - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months iobiotech.com|IOBT - Earnings per share growth rate in current year|Earnings growth forecast for next year IO Biotech, Inc.
Comprehensive company analysis:IO Biotech, IOBT
Manufactured product of IO Biotech, Inc.

This indicator measures the annual change in net profit per share on a quarterly basis. The formula captures earnings dynamics that are sensitive to any fluctuations in operating expenses and one-time payments. The quarterly EPS growth trajectory on the GURU.Markets platform visualizes market momentum and the risk of asset overvaluation. For IO Biotech, Inc. (IOBT), the volatility of this metric is driven by large-scale R&D investments and stock option programs for leading scientists. High costs associated with retaining PhD specialists directly determine the amplitude of this indicator.

Competitors of IO Biotech, Inc.

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Janux Pharma|Year-over-year net earnings per share growth for the last 12 months Arcus Corp (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc. (ZYME)|Year-over-year net earnings per share growth for the last 12 months tangotx.com TNGX|Iovance Biotherapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics NV IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (Compass Therapeutics Corp) - Year-over-year earnings per share growth for the last 12 months|Replimune Group, Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months lyell.com (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months STRO|Quarterly EPS earnings growth INKT (MiNK Therapeutics, Inc.)|Year-over-year earnings per one share growth for the last 12 months HOWL|Immix - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months alxoncology.com|Cue Biopharma (CUE) - Year-over-year earnings per share growth for the last twelve months|PDS Biotechnology Corporation - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIABiotech.com|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Corp - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics Inc (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Tx - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Sensei Biotherapeutics SNSE|Theriva Biologics (TOVX) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Gritstone bio (GRTS)|Year-over-year net earnings per share growth for the last 12 months KA|NEXI: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TSBX|Year-over-year earnings per share growth for the last twelve months VCNX (vaccinex.com)|Quarterly EPS earnings growth HARP (Harpoon Therapeutics, Inc.)